The second quarter’s results will be reported by lithium producer Livent Corp. (NYSE: LTHM) in a month. Wall Street experts predict that the business will once more considerably outperform revenue and earnings expectations. The primary factors are the rising cost of lithium and the steady demand for this metal.
According to Wall Street predictions, sales will increase by more than 100% year over year in the second quarter of 2022. Livent Corp.’s (LTHM)s profit growth might be six times greater than the company’s sales growth in the face of escalating lithium costs.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
Recall that a lack of the metal required for the manufacture of lithium-ion batteries for electric vehicles caused a rise in the price of lithium. For contrast, Livent Corp. (LTHM)’s sales climbed by 56% year over year in the first quarter of this year, but profit increased by more than 1,000% year over year as a result of higher prices.
Investors also predict that LTHM will outline plans to increase output at the time the report is published. The corporation is now putting many initiatives into action to boost the production of lithium hydroxide and carbonate.
The project to increase the state of North Carolina’s ability to produce hydroxide is the one that is most near to being put into operation. The business announced last quarter that it anticipated the facility’s commercial production to start in the second half of this year.
Recall that the Livent Corp. (LTHM) management provided an updated prognosis for the entire year 2022 a few months ago. As anticipated, sales in 2022 would be in the $755 to $835 million range, or over 90% more than in the previous year. For 2022, adjusted EBITDA will rise by 360% to a range of $290-350 million.
The value of the LTHM share at the July 12 auction was $20.79. This indicates a drop of about 40% from the 52-week high, but the company’s prices are still approximately 8% higher than they were at the start of the year.
